Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 5:28 AM ET

Pharmaceuticals

Company Overview of DSM Pharmaceuticals, Inc.

Company Overview

DSM Pharmaceuticals, Inc. provides custom manufacturing services to the pharmaceutical and biopharmaceutical industries. It offers a range of manufacturing services in the areas of steriles, and orals and topicals, including dose form manufacturing, scheduled drugs, clinical manufacturing, fill finish manufacturing, aseptic filling, terminal sterilization, cold storage, ampoules, vials, and lyophilization. The company was formerly known as Catalytica Pharmaceuticals, Inc. and changed its name to DSM Pharmaceuticals, Inc. in December 2001. The company was founded in 1993 and is based in Greenville, North Carolina. DSM Pharmaceuticals, Inc. operates as a subsidiary of DSM Pharmaceutical Produc...

5900 Martin Luther King Jr. Highway

Greenville, NC 27834-8628

United States

Founded in 1993

Phone:

252-758-3436

Fax:

252-707-2046

Key Executives for DSM Pharmaceuticals, Inc.

Chairman of Managing Board
Age: 66
Deputy Chairman of Managing Board
Age: 65
Member of Managing Board
Age: 55
Member of Managing Board
Age: 55
Compensation as of Fiscal Year 2014.

DSM Pharmaceuticals, Inc. Key Developments

Discovery Laboratories Inc. Enters Master Services Agreement with DSM Pharmaceuticals, Inc

On October 24, 2013, Discovery Laboratories entered into a Master Services Agreement with DSM Pharmaceuticals, Inc. DSM is a contract manufacturing organization (CMO) with experience in the manufacture of lyophilized products and with whom the Company has completed a technology transfer of its lyophilized KL4 surfactant manufacturing process. The Agreement is intended to support further development and manufacture of the Company’s lyophilized KL4 surfactant for the Company’s pipeline programs, primarily AEROSURF. Pursuant to the Agreement, DSM will perform certain development and manufacturing activities relating to the Product as may be requested by the company and as may be agreed by the parties in one or more statements of work. Such activities could include but are not limited to equipment procurement and installation, validation master planning, regulatory support, quality assurance support, manufacture of engineering lots and development lots to support the Company’s preclinical, clinical, research and development activities, potential scale-up activities and potential manufacture of process validation lots.

Similar Private Companies By Industry

Company Name Region
Doctor's Natural Solutions Inc. United States
Alitair Pharmaceuticals, Inc. United States
Heaven Sent Naturals, Inc. United States
Mayne Pharma (USA), Inc. United States
Miravant Pharmaceuticals Inc United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DSM Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.